Personalis Inc
Follow $PSNL
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PSNL by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PSNL moving today?
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PSNL overview
Related filings and maps
Congress activity in PSNL
No receipt-qualified Congressional disclosure is present for PSNL in the cached public ledger.
PSNL contract awards, year to date.
Public federal awards linked to this ticker.
PSNL lobbying filings, year to date.
Registered lobbying filings matched to Personalis Inc.